leadXpro, FIRST TENANT OF PARK INNOVAARE’S NEW INNOVATION CAMPUS
Construction of the 23,000m2 new campus has begun. One month after the groundbreaking ceremony, leadXpro is the first company to ascertain its position...
More details More detailsVilligen – Boston – Villigen: Successful Business Trip for InterAx Biotech AG
InterAx Biotech AG participated in a “business boosting” week in Boston, USA, in June, 2016. As part of venturelab’s international program, 10 high...
More detailsTagesschau about PARK INNOVAARE
Together with leadXpro, SRF camera team visits the SwissFEL accelerator On the occasion of the official launch of Switzerland Innovation Park in Bern...
More detailsleadXpro one year in operation: all goals achieved, and even more!
Today, leadXpro AG, one of PARK INNOVAARE’s residents, celebrates its first anniversary and breathtaking development as a company in its first year of...
More detailsleadXpro about possibilities of new XFEL for applied research
Biotech startup leadXpro AG, at home at PARK INNOVAARE, applies serial crystallography among many other methods for structure-based drug design. It recently...
More detailsLEADXPRO SCIENTISTS CHART THE FUTURE OF STRUCTURE BASED DRUG DISCOVERY
In a series of scientific publications leadXpro AG scientists explore the utility of cutting-edge X-ray technologies for the discovery of new therapeutics. Medicines...
More detailsLife Science basic research on the top level
The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s...
More detailsUnprecedented speed and success rate with delivering ligand-bound GPCR structures
Modern drug discovery greatly benefits from knowledge of how a drug interacts with its molecular drug target. Membrane protein drug targets represent a...
More detailsleadXpro “unlocks” new targets for structure-based drug discovery
One of the most promising groups of drug targets is that of integral membrane proteins. They are responsible for communicating signals from the outside...
More detailsState-of-the-art bioinformatics for better drug discovery
The effect a drug has on the human body depends on how well its active substance find its way to the targeted cells in the body, and on the chemical reactions...
More detailsBiosensors Technology Platform for efficient lead discovery
In April 2016, the team at InterAx Biotech AG mounted the nameplate of a newly-born company on the wall of PARK INNOVAARE’s deliveryLAB, thus giving...
More detailsHigh-tech companies learned first-hand about PARK INNOVAARE
PARK INNOVAARE-Management, existing shareholders and spin-off-companies already operating at PARK INNOVAARE informed potential new shareholders about current...
More details